BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 28082726)

  • 1. Multi-modality imaging to assess metabolic response to dichloroacetate treatment in tumor models.
    Neveu MA; De Preter G; Joudiou N; Bol A; Brender JR; Saito K; Kishimoto S; Grégoire V; Jordan BF; Krishna MC; Feron O; Gallez B
    Oncotarget; 2016 Dec; 7(49):81741-81749. PubMed ID: 28082726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic Modulation of Clear-cell Renal Cell Carcinoma with Dichloroacetate, an Inhibitor of Pyruvate Dehydrogenase Kinase.
    Kinnaird A; Dromparis P; Saleme B; Gurtu V; Watson K; Paulin R; Zervopoulos S; Stenson T; Sutendra G; Pink DB; Carmine-Simmen K; Moore R; Lewis JD; Michelakis ED
    Eur Urol; 2016 Apr; 69(4):734-744. PubMed ID: 26433571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer.
    Roh JL; Park JY; Kim EH; Jang HJ; Kwon M
    Cancer Lett; 2016 Feb; 371(1):20-9. PubMed ID: 26607904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor and chemosensitizing action of dichloroacetate implicates modulation of tumor microenvironment: a role of reorganized glucose metabolism, cell survival regulation and macrophage differentiation.
    Kumar A; Kant S; Singh SM
    Toxicol Appl Pharmacol; 2013 Nov; 273(1):196-208. PubMed ID: 24051182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acidosis-induced metabolic reprogramming in tumor cells enhances the anti-proliferative activity of the PDK inhibitor dichloroacetate.
    Schoonjans CA; Joudiou N; Brusa D; Corbet C; Feron O; Gallez B
    Cancer Lett; 2020 Feb; 470():18-28. PubMed ID: 31812695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid Chromatography-Tandem Mass Spectrometry Method Revealed that Lung Cancer Cells Exhibited Distinct Metabolite Profiles upon the Treatment with Different Pyruvate Dehydrogenase Kinase Inhibitors.
    Zhang W; Hu X; Zhou W; Tam KY
    J Proteome Res; 2018 Sep; 17(9):3012-3021. PubMed ID: 30028142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superior anti-tumor efficacy of diisopropylamine dichloroacetate compared with dichloroacetate in a subcutaneous transplantation breast tumor model.
    Su L; Zhang H; Yan C; Chen A; Meng G; Wei J; Yu D; Ding Y
    Oncotarget; 2016 Oct; 7(40):65721-65731. PubMed ID: 27582548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo evaluation of tumour acidosis for assessing the early metabolic response and onset of resistance to dichloroacetate by using magnetic resonance pH imaging.
    Anemone A; Consolino L; Conti L; Reineri F; Cavallo F; Aime S; Longo DL
    Int J Oncol; 2017 Aug; 51(2):498-506. PubMed ID: 28714513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic Resonance Imaging Is More Sensitive Than PET for Detecting Treatment-Induced Cell Death-Dependent Changes in Glycolysis.
    Hesketh RL; Wang J; Wright AJ; Lewis DY; Denton AE; Grenfell R; Miller JL; Bielik R; Gehrung M; Fala M; Ros S; Xie B; Hu DE; Brindle KM
    Cancer Res; 2019 Jul; 79(14):3557-3569. PubMed ID: 31088837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of dichloroacetate (DCA) on lactate production and oxygen consumption in neuroblastoma cells: is DCA a suitable drug for neuroblastoma therapy?
    Niewisch MR; Kuçi Z; Wolburg H; Sautter M; Krampen L; Deubzer B; Handgretinger R; Bruchelt G
    Cell Physiol Biochem; 2012; 29(3-4):373-80. PubMed ID: 22508045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of dichloroacetate in canine prostate adenocarcinomas and transitional cell carcinomas in vitro.
    Harting T; Stubbendorff M; Willenbrock S; Wagner S; Schadzek P; Ngezahayo A; Murua Escobar HM; Nolte I
    Int J Oncol; 2016 Dec; 49(6):2341-2350. PubMed ID: 27748833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel molecular mechanisms of antitumor action of dichloroacetate against T cell lymphoma: Implication of altered glucose metabolism, pH homeostasis and cell survival regulation.
    Kumar A; Kant S; Singh SM
    Chem Biol Interact; 2012 Jul; 199(1):29-37. PubMed ID: 22705712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of three modifiers of glycolysis on ATP, lactate, hypoxia, and growth in human tumor cell lines in vivo.
    Yaromina A; Meyer S; Fabian C; Zaleska K; Sattler UG; Kunz-Schughart LA; Mueller-Klieser W; Zips D; Baumann M
    Strahlenther Onkol; 2012 May; 188(5):431-7. PubMed ID: 22349632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dichloroacetate induces apoptosis and cell-cycle arrest in colorectal cancer cells.
    Madhok BM; Yeluri S; Perry SL; Hughes TA; Jayne DG
    Br J Cancer; 2010 Jun; 102(12):1746-52. PubMed ID: 20485289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimodality Imaging Identifies Distinct Metabolic Profiles In Vitro and In Vivo.
    Neveu MA; De Preter G; Marchand V; Bol A; Brender JR; Saito K; Kishimoto S; Porporato PE; Sonveaux P; Grégoire V; Feron O; Jordan BF; Krishna MC; Gallez B
    Neoplasia; 2016 Dec; 18(12):742-752. PubMed ID: 27889643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dichloroacetate improves immune dysfunction caused by tumor-secreted lactic acid and increases antitumor immunoreactivity.
    Ohashi T; Akazawa T; Aoki M; Kuze B; Mizuta K; Ito Y; Inoue N
    Int J Cancer; 2013 Sep; 133(5):1107-18. PubMed ID: 23420584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential modulation of glucose, lactate, and pyruvate oxidation by insulin and dichloroacetate in the rat heart.
    Lloyd S; Brocks C; Chatham JC
    Am J Physiol Heart Circ Physiol; 2003 Jul; 285(1):H163-72. PubMed ID: 12793977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia enhances antitumor activity of dichloroacetate.
    Kolesnik DL; Pyaskovskaya ON; Boichuk IV; Solyanik GI
    Exp Oncol; 2014 Dec; 36(4):231-5. PubMed ID: 25537215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the low inhibitory specificity of oxamate, aminooxyacetate and dichloroacetate on cancer energy metabolism.
    Moreno-Sánchez R; Marín-Hernández Á; Del Mazo-Monsalvo I; Saavedra E; Rodríguez-Enríquez S
    Biochim Biophys Acta Gen Subj; 2017 Jan; 1861(1 Pt A):3221-3236. PubMed ID: 27538376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Targeting of the Warburg Effect in Pancreatic Cancer Relies on an Absence of p53 Function.
    Rajeshkumar NV; Dutta P; Yabuuchi S; de Wilde RF; Martinez GV; Le A; Kamphorst JJ; Rabinowitz JD; Jain SK; Hidalgo M; Dang CV; Gillies RJ; Maitra A
    Cancer Res; 2015 Aug; 75(16):3355-64. PubMed ID: 26113084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.